Budralazine (INN) is a vasodilator.[1][2]
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C14H16N4 |
Molar mass | 240.310 g·mol−1 |
3D model (JSmol) | |
|
References
edit- ^ Akashi A, Chiba T, Suzuki I, Hashimoto H (September 1978). "Pharmacology of budralazine, a new antihypertensive drug". Archives Internationales de Pharmacodynamie et de Thérapie. 235 (1): 134–46. PMID 736687.
- ^ Yoshioka M, Minami M, Saito H (1991). "The anti-tachycardic mechanism of a direct-acting vasodilator, budralazine, in rats". Clinical and Experimental Hypertension, Part A. 13 (5): 1107–14. doi:10.3109/10641969109042116. PMID 1773498.